homebusiness Newscompanies News

Zydus to supply product to US firm Sagent from Gujarat plant

Zydus to supply product to US firm Sagent from Gujarat plant

Zydus to supply product to US firm Sagent from Gujarat plant
Profile image

By PTI Apr 13, 2022 1:58:19 PM IST (Updated)

Caffeine Citrate Oral Solution is indicated for short-term treatment of a breathing problem (Apnea) in premature infants

Zydus Lifesciences on Wednesday said it will supply Caffeine Citrate Oral Solution from its Gujarat-based manufacturing plant to US-based Sagent Pharmaceuticals, Inc.

Recommended Articles

View All

The company will be manufacturing and supplying Caffeine Citrate Oral Solution in the strengths of 60mg per 3 ml (20mg per ml) single-dose vial from its injectables facility at Jarod in Gujarat, Zydus Lifesciences said in a statement.
Zydus said it has received Prior Approval Supplement (PAS) approval from the US Food and Drug Administration (USFDA), which allows for a site transfer and manufacturing of the drug at Jarod.
Also Read:
Caffeine Citrate Oral Solution is indicated for short-term treatment of a breathing problem (Apnea) in premature infants. Caffeine blocks certain proteins (adenosine receptors) which leads to improved breathing in infants suffering from Apnea.
The US-based Sagent Pharmaceuticals is a specialty pharmaceutical company focused on developing, manufacturing, sourcing, and marketing pharmaceutical products for the North American market, with a specific emphasis on injectables.
PAS is an application which seeks to make changes to an already approved application, such as an Abbreviated New Drug Application (ANDA), which is used by the USFDA to approve generic drugs.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers
    CurrencyCommodities
    CompanyPriceChng%Chng